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Introduction
Sarcoidosis is a multisystem disease of unknown origin,
characterized by widespread, non-caseating epithe-
lioid cell granuloma. The condition may affect the
chest, skin, eyes, liver, spleen, lymph nodes, glands,
heart, renal system, bones, joints, central nervous sys-
tem and other organs or tissues. Diagnosis of sar-
coidosis is based on histologic evidence together with
compatible clinical findings.1,2 Clinicopathologic cor-
relation is essential, and the presence of non-caseating
granuloma with negative staining for acid fast organ-
isms and fungi is suggestive of the diagnosis.
Transbronchial and mediastinal biopsy are the most
common tissue sites tested for sarcoidosis. Other biopsy
sites include cutaneous lesions, the liver, and extra-
pulmonary peripheral lymph nodes.3 Conjunctival
biopsy was described in the 1950s, and is considered
to be a simple, safe and specific diagnostic procedure
for sarcoidosis.4–7 Nonetheless, it is still considered
controversial and is not a popular choice for biopsy.
This study was designed to determine the value of
random, bilateral conjunctival biopsy in the diagnosis
of sarcoidosis.
Methods
Diagnosis of sarcoidosis was based on the presence of
non-caseating granuloma on tissue biopsy along with
compatible clinical findings. Other granuloma-forming
processes, such as tuberculosis, fungal infection and
various foreign bodies, were excluded.1,2
This study was prospectively conducted from
December 2003 to April 2005 in the uveitis clinic of
Taipei Veterans General Hospital. All patients with
peculiar uveitis features indicative of sarcoidosis8 or
those with a definitive diagnosis of sarcoidosis who
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were referred for evaluation of ocular involvement were
suggested to receive conjunctival biopsy. Patients who
were subsequently diagnosed with sarcoidosis as well as
those with their diagnosis established before conjunc-
tival biopsy were enrolled into this study.
The conjunctival biopsy was performed under sub-
conjunctival anesthesia with 1–2 mL 2% lidocaine with
1:100,000 epinephrine. The lower eyelid was retracted,
and a sample of conjunctiva measuring approximately
1 cm in length and 0.3 cm in width was excised from
the inferior fornix with Westcott scissors (Figure 1).
Hemostasis was achieved by applying pressure to the
eye for 3 minutes. Prophylactic antibiotic ointment
was then instilled into the lower fornix. All patients
underwent bilateral biopsies.
The excised conjunctival tissue was fixed in 10% for-
malin and embedded in paraffin blocks. The embed-
ded tissue was sectioned at 5 μm at multiple levels,
then stained with hematoxylin and eosin. A positive
result was defined as the presence of non-caseating
granuloma. To exclude other granuloma-forming pro-
cesses, stains such as Kinyoun stain for acid-fast bacilli
and Gomori methenamine silver and Periodic Acid–
Schiff stain for fungi were performed (Figure 2).
The modified Scadding classification of lung involve-
ment based on chest radiograph findings has been
widely accepted. Stage 0 means no abnormality; Stage I,
lymph node enlargement; Stage II, lymph node
enlargement accompanied by pulmonary infiltration;
Stage III, pulmonary infiltration with no lymph node
enlargement; and Stage IV, evidence of pulmonary
fibrosis with retraction of the hilar areas cephalad,
cystic changes and bullae.1
Data regarding age at diagnosis, gender, initial
symptoms, tissue proof sites, disease stage by chest 
X-ray and high-resolution computed tomography
(CT), presence of uveitis, and conjunctival biopsy
results were collected and analyzed. To assess the dif-
ferences between patients with positive and negative
biopsy results, categorical variables were analyzed using
either the χ2 test or Fisher’s exact test. Goodman and
Kruskal’s Gamma test was used when ordinal variables
were to be compared. Values of p<0.05 were consid-
ered statistically significant.
Results
A total of 32 cases of sarcoidosis were examined, and 
29 patients received conjunctival biopsy. Of these 29
patients, 22 had peculiar uveitis manifestations sug-
gestive of sarcoidosis. Seven patients referred by
pulmonologists for evaluation of ocular involvement 
of sarcoidosis were enrolled in this study (Table 1). All
of the 29 patients (7 men, 22 women) were Chinese
living in Taiwan. The mean age at diagnosis was
47.8 ± 12.4 years (range, 22–76 years). The most com-
mon initial symptom was eye-related problems in 19
(65.5%) cases. Ocular problems included blurred vision
and floaters, and all patients were referred with the diag-
nosis of uveitis. Abnormal chest X-ray film on physical
examination, respiratory problems and skin lesions were
noted in 4 (13.8%), 3 (10.3%), and 2 (6.9%) patients,
respectively. One patient presented with unexplained
body weight loss.
The diagnosis of sarcoidosis was established before
the time of conjunctival biopsy in 10 patients. The 
tissue proof sites were a mediastinal lymph node in 
4 cases, lung parenchyma in 4, skin in 4, and supra-
clavical lymph node in 1 case. Conjunctival biopsy was
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Figure 1. Conjunctival biopsy about 1 cm in length and 0.3 cm in
width is taken from the inferior fornix, with no suturing.
Figure 2. Conjunctival biopsy specimen shows non-caseating
granulomas; the arrow indicates a multinucleate giant cell (hema-
toxylin & eosin, 200´).
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positive in 3 of these 10 patients and 8 of the other 19
patients in whom sarcoidosis was suspected on the
basis of clinical presentation. The conjunctiva was the
sole site of tissue proof in 6 patients. These 6 were all
female, and presented with typical features of sarcoid
uveitis. In the 11 patients with negative conjunctival
biopsy results, sarcoidosis was subsequently confirmed
by biopsy of the mediastinal lymph node in 8 patients
and lung parenchyma in 3. The chest conditions at the
time of conjunctival biopsy were stage 0 in 12 patients,
stage 1 in 12, stage 2 in 1, and stage 3 in the other 4
patients on chest X-ray examination. Chest CT revealed
more advanced disease stage with stage 0 for 2 patients,
stage 1 for 14 patients, stage 2 for 11 patients, and stage
3 for 2 patients. One particular case involved a 22-year-
old man (case 1) referred with recurrent uveitis lasting
1 year. Ocular presentation with choroidal nodules
and retinal vasculitis in both eyes strongly suggested
sarcoidosis. Although chest CT and X-ray findings were
negative, bronchoalveolar lavage revealed marked lym-
phocytosis with an increased ratio of 3.5 of CD4/CD8
and decreased peripheral blood. The patient received
another bronchoscopic examination 3 months later, and
non-caseating epithelioid granulomas were demon-
strated on transbronchial lung biopsy.
Of 58 biopsy specimens from 29 patients, 15
(25.9%) specimens in 11 (37.9%) patients proved to
be positive. Of the positive biopsy specimens, 4 (13.8%)
patients had bilateral involvement; the other 7 (24.1%)
had unilateral involvement.
Regarding the appearance of the conjunctiva prior
to biopsy, prominent nodules only were found in 
Table 1. Demographic and clinical characteristics of 29 patients with sarcoidosis who received conjunctival biopsy
No.
Age at 
Sex
Initial
Diagnosis of Tissue 
Chest Chest
Uveitis
Conjunctival biopsy
diagnosis sarcoidosis before proof 
(yr) 
symptoms
conjunctival biopsy sites
X-ray CT
Right side Left side
1 22 M Eye No L 0 0 + − −
2 49 F Eye No C 0 2 + − +
3 28 F Chest No MLN 1 1 + − −
tightness
4 50 F Eye No C 0 1 + + −
5 56 F Eye Yes MLN 1 1 + − −
6 50 F Eye No MLN, C 3 2 + + −
7 42 M Routine No MLN 1 1 − − −
8 64 F Eye No L 3 3 + − −
9 40 F Eye No MLN 1 1 + − −
10 32 M Cough Yes C, L 3 2 − − +
11 23 F Eye No MLN 1 2 + − −
12 55 F Eye Yes C, L, S 3 2 + + +
13 29 M Routine Yes L 0 1 − − −
14 51 F Eye No C 0 2 + + −
15 50 F Eye No C 0 0 + + +
16 53 F Eye No C 0 1 + + −
17 55 F Eye No L 0 3 + − −
18 40 M Routine Yes MLN 1 1 − − −
19 44 F Body weight Yes MLN, S, SLN 1 2 + − −
loss
20 46 F Cough Yes MLN 1 2 − − −
21 46 F Eye No MLN 0 1 + − −
22 67 F Eye No MLN 2 2 + − −
23 53 F Skin Yes S 0 2 + − −
24 56 F Eye No MLN 1 1 + − −
25 51 F Eye No C 1 1 + + −
26 54 M Eye No MLN, C 1 2 + + +
27 49 F Skin Yes S, C 0 1 − + +
28 76 M Eye No MLN 0 1 + − −
29 56 F Routine Yes L 1 1 − − −
+ = positive; − = negative; C = conjunctiva; CT = computed tomography; L = lung parenchyma; MLN = mediastinal lymph node; S = skin; SLN = supraclavical
lymph node.
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1 patient, but revealed a negative result. No promi-
nent nodular or follicular changes were observed in
the other 28 (96.6%) patients. Generally, a swollen
conjunctiva with subtle fibrotic appearance revealed a
high probability of positive results.
Comparisons of patient profiles, including gender,
age at diagnosis by decade, presence of uveitis, initial
symptoms, and chest conditions examined by chest 
X-ray and CT, revealed no significance between positive
and negative conjunctival biopsy results (Table 2).
No biopsy-related complications or morbidity
occurred in this study.
Discussion
Epidemiology studies indicate that sarcoidosis is rarely
seen among Chinese.9,10 The most common ocular
manifestation in sarcoidosis is uveitis.2,11 The pattern
of uveitis in a given population is strongly influenced by
various genetic, geographic and environmental factors.
Uveitis with sarcoidosis occurs in about 20% of uveitis
patients in many geographic areas, including the
United States, Japan and the cities of Amsterdam and
Rotterdam.12 In a large study conducted in China, sar-
coidosis was absent in 1,752 uveitis patients.13 As
noted in our previous report, uveitis with sarcoidosis
is extremely rare, occurring in only 1 of 240 cases of
uveitis from 1984 to 1986 in this clinic.14 However,
there has been a notable increase in the number of
patients with uveitis that consequently led to the diag-
nosis of sarcoidosis.15
Granulomas are usually widely distributed, so the
biopsy site should be determined by risk assessment
versus the likelihood of success. A study by Bornstein
et al5 evaluated conjunctival biopsy in sarcoidosis in 3
patient groups. Group 1 consisted of 52 patients with
biopsy-confirmed sarcoidosis in whom tissue other
than conjunctiva yielded non-caseating granulomas.
Group 2 consisted of 12 patients suspected of having
Table 2. Comparison of variables between positive (n = 11) and negative (n = 18) conjunctival biopsy results
Biopsy result
Positive, n (%) Negative, n (%)
p
Gender 0.678*
Male 2 (28.6) 5 (71.4)
Female 9 (40.9) 13 (59.1)
Age at diagnosis (yr) 0.334†
21–30 0 (0) 4 (100)
31–40 1 (33.3) 2 (66.7)
41–50 5 (55.6) 4 (44.4)
51–60 5 (50.0) 5 (50.0)
> 60 0 (0) 3 (100)
Uveitis 0.677*
With 9 (40.9) 13 (59.1)
Without 2 (28.6) 5 (71.4)
Initial symptoms 0.234*
Ocular 9 (47.4) 10 (52.6)
Extraocular 2 (20.0) 8 (80.0)
Disease stage by CXR 0.317†
Stage 0 6 (50.0) 6 (50.0)
Stage 1 2 (16.7) 10 (83.3)
Stage 2 0 (0) 1 (100)
Stage 3 3 (75.0) 1 (25.0)
Disease stage by chest CT 0.373†
Stage 0 1 (50.0) 1 (50.0)
Stage 1 4 (28.6) 10 (71.4)
Stage 2 6 (54.5) 5 (45.5)
Stage 3 0 (0) 2 (100)
*Fisher’s exact test; †Goodman and Kruskal’s Gamma test. CXR = chest X-ray; CT = computed tomography.
sarcoidosis. These patients had clinical manifestations
either typical or strongly suggestive of sarcoidosis.
Except for conjunctival biopsy, a biopsy procedure was
either not performed, or, if performed, was negative for
granuloma. In both study groups, intensive and repeated
investigations were unsuccessful in disclosing an infec-
tious or chemical etiologic agent. Group 3 consisted
of 28 patients without sarcoidosis. Conjunctival biopsy
was performed because sarcoidosis entered into the
differential diagnosis during the course of the illness.
Eleven patients had infectious granulomatous disease,
either tuberculosis or histoplasmosis. The remaining
cases consisted of varied medical diseases. The resear-
chers concluded that false-positive reactions were not
observed in patients with varied disease other than sar-
coidosis. In another study conducted by Khan et al,16
100 conjunctival biopsies were performed on patients
with histologically confirmed sarcoidosis (60 biopsies),
pulmonary tuberculosis (25 biopsies), and several non-
specific inflammatory diseases of the lung and eye (15
biopsies). A positive biopsy was present in 33% of the
patients with sarcoidosis, but in none of the patients
with other disease processes. Khan et al16 suggested
that this procedure, due to its ease, safety and speci-
ficity, should be the first biopsy performed in patients
with clinical or chest X-ray abnormalities suggesting
sarcoidosis. Saer et al17 obtained 58 postmortem con-
junctival biopsies from 30 patients without sarcoido-
sis. Although aggregates of foreign body giant cells
were observed in 3 specimens (5.2%), no distinct, non-
caseating granuloma formation was seen. Therefore,
the researchers concluded that non-caseating granu-
loma, which is used as the diagnostic feature of sarcoido-
sis, does not appear to be a hindrance in the diagnosis of
sarcoidosis based on the presence of granuloma in the
conjunctival biopsy specimen.
Cost-effectiveness evaluation of biopsy sites revealed
that conjunctival biopsy performed in the outpatient
setting was less expensive than any of the other biopsy
procedures. In fact, 10 conjunctival biopsies could be
performed for the same cost as 1 mediastinoscopy,
and 5 conjunctival biopsies for the same cost as 1
transbronchial biopsy.18
Nodular lesion is the most common manifestation
in sarcoidosis with conjunctival involvement.2,11,19,20
Multiple or solitary yellow nodules are the most fre-
quently seen lesions.11 In a series of sarcoidosis patients
followed at the Massachusetts Eye and Ear Infirmary,
conjunctival nodules were seen more frequently in
patients younger than 35 years of age. Thirty percent
of eyes in patients younger than 35 years old devel-
oped conjunctival nodules versus 5% of eyes in patients
older than 35 years.21 On the other hand, the rate of
positive biopsy was almost no different (24% vs. 20%)
in either group presenting with conjunctival nodules.
However, over half of the patients without conjuncti-
val lesions had a positive biopsy.18 As in the study by
Khan et al, the Massachusetts Eye and Ear Infirmary
study found that it was not possible to predict which
patient would have a positive conjunctival biopsy.16
In our study, we found that none of the patients with
positive results had prominent nodular or follicular
changes. To a certain degree, a swollen, subtle f ibrotic
appearance revealed relatively positive results in our
series. However, this finding does not predict the real
situation. So, a blind method of evaluation is recom-
mended.
The results regarding the positive rate upon con-
junctival biopsy vary among studies. Table 3 summa-
rizes the incidence of positive conjunctival biopsies in
sarcoidosis patients, which range from 27% to 55%,
with a mean of 37.4%.5,7,16,18,22,23 Our incidence of
37.9% positive biopsy was nearly the same as those of
other ethnic groups.
There was no association between the presence of
uveitis and a positive conjunctival biopsy for sarcoido-
sis in this study. This tendency had also been observed
in previous studies.16,23 Furthermore, there is also no
significant association with gender, age at diagnosis,
initial symptoms, and chest condition.
In conclusion, conjunctival biopsy may provide a
simple and rapid means of distinguishing uveitis due
to sarcoidosis. This biopsy may further confirm the diag-
nosis of sarcoidosis when other biopsies have failed to
do so or cannot be performed. Furthermore, blinded
bilateral conjunctival biopsy should be considered as a
diagnostic tool before other invasive methods.
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